Tetra Bio-Pharma Inc. (TBPMQ)

Tetra Bio-Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is December - November.

Fiscal Year	Current	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	May 14, 2025	Nov 30, 2021	Nov 30, 2020	Nov 30, 2019	Nov 30, 2018	Nov 30, 2017
Market Capitalization	0	70	42	60	128	64
Market Cap Growth	-79.46%	67.18%	-31.11%	-52.76%	99.22%	282.26%
Enterprise Value	-	65	33	56	118	62
Last Close Price	0.00	0.17	0.15	0.28	0.78	0.54
PB Ratio	0.00	356.91	2.39	3.25	8.14	7.77
P/TBV Ratio	-	356.91	-	47.33	13.88	32.85
Debt / Equity Ratio	-0.28	12.48	0.09	-	-	-
Quick Ratio	0.23	0.70	0.47	0.60	5.64	4.78
Current Ratio	0.25	0.82	0.53	1.38	5.71	5.00
Return on Equity (ROE)	-315.85%	-456.91%	-89.56%	-57.45%	-49.76%	-111.25%
Return on Assets (ROA)	-38.52%	-81.72%	-44.23%	-31.45%	-43.64%	-65.60%
Return on Capital (ROIC)	-52.48%	-107.85%	-52.01%	-35.91%	-47.85%	-69.37%
Earnings Yield	-5782697.29%	-58.63%	-49.01%	-19.05%	-4.45%	-7.53%
FCF Yield	-1214644.19%	-28.78%	-36.80%	-21.94%	-5.59%	-4.71%
Buyback Yield / Dilution	-26.48%	-55.60%	-37.14%	-29.21%	-35.15%	-66.33%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.